IRMD - IRadimed Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue30,438.98323,081.59232,496.54831,228.85
Cost of Revenue7,211.6335,569.8966,154.8365,475.537
Gross Profit23,227.3517,511.69626,341.71225,753.313
Operating Expenses
Research Development1,517.1121,722.5641,347.5071,764.306
Selling General and Administrative15,706.46814,298.67914,074.15112,420.425
Non Recurring----
Others----
Total Operating Expenses24,435.21321,796.58321,576.49419,660.268
Operating Income or Loss6,003.771,285.00910,920.05411,568.582
Income from Continuing Operations
Total Other Income/Expenses Net193.537111.37732.6865.952
Earnings Before Interest and Taxes6,003.771,285.00910,920.05411,568.582
Interest Expense----
Income Before Tax6,197.3071,396.38610,952.73411,634.534
Income Tax Expense-106.143896.6223,738.1894,104.614
Minority Interest----
Net Income From Continuing Ops6,303.45499.7647,214.5457,529.92
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income6,303.45499.7647,214.5457,529.92
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares6,303.45499.7647,214.5457,529.92